Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 2, 2010, Pages 244-245

  Fava, P ^a   Stroppiana, E ^a   Savoia, P ^a   Bernengo, Mg ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB;

ADULT; CANCER PATIENT; CASE REPORT; CAUCASIAN; DERMATOFIBROSARCOMA PROTUBERANS; DRUG MECHANISM; DRUG WITHDRAWAL; FACE EDEMA; FOLLOW UP; HALO EFFECT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINAL REGION; LETTER; MALE; NEVUS; PAPULAR RASH; PRIORITY JOURNAL; SURGICAL APPROACH; SURGICAL RISK; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; DERMATOFIBROSARCOMA; HUMANS; MALE; MIDDLE AGED; NEVUS, HALO; PIPERAZINES; PYRIMIDINES; SKIN NEOPLASMS;

EID: 74549190954     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03404.x     Document Type: Letter

References (10)

1. Bixby DL, Talpaz M. Efficacy of various doses and schedules of second-generation tyrosine kinase inhibitors. Clin Lymphoma Myeloma 2008 8 (Suppl. 3 S95 S106.
2. Savoia P, Ortoncelli M, Quaglino P et al. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study. Dermatol Surg 2006 32 : 1097 1102.
3. Valeyrie L, Bastuji-Garin S, Revuz J et al. Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients. J Am Acad Dermatol 2003 48 : 201 206.
4. Etienne G, Cony-Makhoul P, Mahon FX. Imatinib mesylate and gray hair. N Engl J Med 2002 8 : 347 446.
5. Han H, Yu YY, Wang Y. Imatinib mesylate-induced repigmentation of vitiligo lesions in a patient with recurrent gastrointestinal stromal tumors. J Am Acad Dermatol 2008 59 : S80 S83.
6. Raanani P, Goldman JM, Ben Bassat I. Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukaemia patient treated with STI-571. J Clin Oncol 2002 20 : 869 870.
7. Brazzelli V, Roveda E, Prestinari F et al. Vitiligo-like lesions and diffuse lightening of the skin in a pediatric patient treated with imatinib mesylate: a non-invasive colorimetric assessment. Pediatr Dermatol 2006 23 : 175 178.
8. Cario-André M, Pain C, Gauthier Y et al. In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res 2006 19 : 434 442.
9. Alexeev V, Yoon K. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 2006 126 : 945 947.
10. Goding CR. Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. Genes Dev 2000 14 : 1712 1728.